OMEPRAZOLE 20mg R158 (Omeprazole delayed release 20 mg)

Pill imprint OMEPRAZOLE 20mg R158 has been identified as Omeprazole delayed release 20 mg.

Omeprazole is used in the treatment of gerd; barrett's esophagus; gastritis/duodenitis; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Omeprazole delayed release

Imprint:

OMEPRAZOLE 20mg R158

Strength:

20 mg

Color:

Purple / Gray

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Proton pump inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Dr. Reddy’s Laboratories Inc.

National Drug Code (NDC):

55111-0158

Inactive Ingredients:

crospovidone
hypromelloses
magnesium stearate
mannitol
meglumine
methacrylic acid - ethyl acrylate copolymer (1:1) type a
shellac
poloxamer 407
povidone
triethyl citrate
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
FD&C Yellow No. 6
ferric oxide yellow
gelatin
silicon dioxide
sodium lauryl sulfate
titanium dioxide
butyl alcohol
propylene glycol

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
68084-0128	Amerisource Health Services
16590-0176	Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.